about
Heat shock protein-27 (HSP27) regulates STAT3 and eIF4G levels in first trimester human placenta.Sarcoidosis in Israel: Clinical Outcome Status, Organ Involvement, and Long-Term Follow-Up.First trimester human placental factors induce breast cancer cell autophagy.Hormone-dependent placental manipulation of breast cancer cell migration.Fibroblast paracrine TNF-α signaling elevates integrin A5 expression in idiopathic pulmonary fibrosis (IPF).The role of bacterial culture by bronchoscopy in patients with lung cancer: a prospective study.The effect of heat shock protein 27 on extravillous trophoblast differentiation and on eukaryotic translation initiation factor 4E expression.Nintedanib (BIBF 1120) blocks the tumor promoting signals of lung fibroblast soluble microenvironment.First trimester human placenta prevents breast cancer cell attachment to the matrix: The role of extracellular matrix.Placenta-breast cancer cell interactions promote cancer cell epithelial mesenchymal transition via TGFβ/JNK pathway.Peripheral blood telomere alterations in ground glass opacity (GGO) lesions may suggest malignancyFibroblast-matrix interplay: Nintedanib and pirfenidone modulate the effect of IPF fibroblast-conditioned matrix on normal fibroblast phenotypeEBUS-TBNA is Sufficient for Successful Diagnosis of Silicosis with Mediastinal LymphadenopathyTGF-β pathway activation by idiopathic pulmonary fibrosis (IPF) fibroblast derived soluble factors is mediated by IL-6 trans-signalingRole of Transbronchial Cryobiopsy in Interstitial Lung Diseases: An Ongoing TaleSleep Disturbances Can Be Prospectively Observed in Patients with an Inactive Inflammatory Bowel DiseaseRheumatological Assessment Is Important for Interstitial Lung Disease DiagnosisEpidermal growth factor receptor paracrine upregulation in idiopathic pulmonary fibrosis fibroblasts is blocked by nintedanibWrist-Sensor Pulse Oximeter Enables Prolonged Patient Monitoring in Chronic Lung Diseases
P50
Q38742121-0BE9104C-54A6-4C4C-BFD9-6DAB2721C700Q38784228-98C66689-4667-4315-94CD-20B23634FB1BQ38912468-B72B46A2-6069-438E-9018-7456FB41DED7Q39448826-219D1C60-A284-44E0-90AC-C5E87582F62AQ41090863-21550CBC-A70A-462B-A25F-94F84D42FFAFQ47177129-458B5C37-301B-4E3C-8EC7-36A5CC37B241Q50545881-FA9FABB3-0D1C-458C-A319-0BCCAEEF8B58Q53787886-277AE570-D065-467F-A799-D5694D2CEDC7Q53798174-7DC7A2DD-DC02-47D4-BB9E-FEFF3A869236Q54188482-0958691E-D9C2-4C11-8E90-CC0CA142947DQ64106064-9A5230F6-4B71-43D2-8E39-6A004F13DF13Q88036258-F9249592-2C1E-4378-8B8F-2587433EBD17Q88912910-13C2A407-9E2C-407B-A46C-C1B484513094Q89763453-265026CA-72D7-483A-9532-F8600FB5FAFFQ90176466-B6DEE657-C4BE-47B5-8DCB-0FE8A1F7D6FBQ90356853-B8C5F513-7801-4652-95BB-23E145FBCF9FQ90965624-726A6CF5-48A2-4525-BD2B-63EC46562615Q91953734-1AD12C38-C70B-4CF3-9CF4-FB7A0D476C33Q92762837-6B1102D6-3169-4F4B-9C6E-4D8542949DD8
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Gali Epstein Shochet
@ast
Gali Epstein Shochet
@en
Gali Epstein Shochet
@es
Gali Epstein Shochet
@nl
Gali Epstein Shochet
@sl
type
label
Gali Epstein Shochet
@ast
Gali Epstein Shochet
@en
Gali Epstein Shochet
@es
Gali Epstein Shochet
@nl
Gali Epstein Shochet
@sl
prefLabel
Gali Epstein Shochet
@ast
Gali Epstein Shochet
@en
Gali Epstein Shochet
@es
Gali Epstein Shochet
@nl
Gali Epstein Shochet
@sl
P106
P31
P496
0000-0002-3417-9171